Jones Kristi

President and CEO, DirectorNexImmune, Inc. (NEXI) · full profile →Form 4 · filed Apr 6, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
17
0 non-derivative · 17 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 4, 2023Disposed to issuer(D)16K0
Apr 4, 2023Grant(A)16K16K
Apr 4, 2023Grant(A)300K$030K
Apr 4, 2023Disposed to issuer(D)456K0
Apr 4, 2023Grant(A)162K162K
Apr 4, 2023Grant(A)295K295K
Apr 4, 2023Disposed to issuer(D)84K0
Apr 4, 2023Grant(A)54K54K
Apr 4, 2023Grant(A)30K30K
Apr 4, 2023Disposed to issuer(D)19K0
Apr 4, 2023Grant(A)19K19K
Apr 4, 2023Disposed to issuer(D)24K0
Apr 4, 2023Grant(A)24K24K
Apr 4, 2023Disposed to issuer(D)4K0
Apr 4, 2023Grant(A)4K4K
Apr 4, 2023Disposed to issuer(D)88K0
Apr 4, 2023Grant(A)88K88K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-023685) within minutes of acceptance. Every field above traces to the original document. Verify it directly: